Product Program year 2020 Source: CMS Open Payments

Tuzistra XR

Drug antitussive

NDC 69654-480-01

Open in the dashboard

General payments

$4,080

275 payments

Research payments

0 payments

Through program year 2020, $4,080 in general payments and $0 in research payments were reported against Tuzistra XR (antitussive).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows

Year	Kind	Amount	Payments
2020	General	$53	4
2019	General	$4,026	271

Breakdown

Who paid General payments · program years 2019–2020

Aytu BioScience, Inc $4,080 275 payments

Top recipients General payments · program year 2020

Gisele Riscile Family Medicine · Tampa, FL $15 28% · 1 payment
Leonard Cosmo Pulmonary Disease · Tampa, FL $15 27% · 1 payment
Ronald Gurney Gastroenterology · McLean, VA $15 27% · 1 payment
Ahmad Sahebzamani Family Medicine · Bradenton, FL $9 17% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020

Family Medicine $24 45% · 2 practitioners
Pulmonary Disease Internal Medicine $15 27% · 1 practitioner
Gastroenterology Internal Medicine $15 27% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020

Florida $39 73% · 3 recipients
Virginia $15 27% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

Records

275 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.